Arbuthnot, Patrick

Self-amplifying RNA vaccines for infectious diseases

Bloom, K., van den Berg, F., & Arbuthnot, P. (2021) · Gene Therapy

RNA Interference and Gene DeliveryImmunotherapy and Immune Responses

Cited by 487

Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases

Bloom, K., Ely, A., Mussolino, C., Cathomen, T., & Arbuthnot, P. (2013) · Molecular Therapy

Hepatitis B Virus StudiesCRISPR and Genetic Engineering

Cited by 217

Advancing mRNA technologies for therapies and vaccines: An African context

Kairuz, D., Samudh, N., Ely, A., Arbuthnot, P., & Bloom, K. (2022) · Frontiers in Immunology

RNA Interference and Gene DeliverySARS-CoV-2 and COVID-19 Research

Cited by 25

Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines

Kairuz, D., Samudh, N., Ely, A., Arbuthnot, P., & Bloom, K. (2023) · Pharmaceutics

RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery

Cited by 17